CBIO: Crescent Biopharma, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | BALYASNY ASSET MANAGEMENT L.P. | 6.03% | SEC |
Institutional ownership (Q2 2026)
2 institutions reported holding $8.51M of Crescent Biopharma, Inc. on Form 13F (3 the quarter before). 0 opened a new position and 1 sold out. Shares held by institutions: -43%.
| Largest holders | Shares | Value |
|---|---|---|
| Boxer Capital Management, LLC | 453,686 | $8.17M |
| Quadrature Capital Ltd | 19,227 | $346K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.